Duality Biotherapeutics is a clinical-stage biotech company dedicated to the discovery and development of next-generation ADC to treat cancer and autoimmune diseases.

Our Managing Partner, Mr. Vincent Pang, was pleased to be invited as the opening guest for ESG Achievement Awards 2023/2024 Campus Sharing this year. He also had the honor of serving as a moderator of the panel discussion at the campus sharing held on 17 February 2025. Co-organized by HKU Business School and organized by

AVISTA Group’s Shanghai and Beijing offices welcome outstanding university students from Hong Kong University, Hong Kong University of Science and Technology, Hong Kong Polytechnic University, and Chinese University of Hong Kong, among others, as part of the Hong Kong Seeding’s Young Talent Global Career Exploration (GCE) Internship Scheme.

Congratulations to Green Tea Group Limited. (6831.HK) on its successful Listing on the Mainboard of HKSE on 16 May 2025

Breton Technology Co., Ltd. (“Breton”) is a China-based provider of electric-powered engineering machinery.

Chagee Holdings Limited, originated in Yunnan, China, primarily engaged in the provision of the Chinese-style tea drinks brand – Chagee.

We are pleased to announce that AVISTA has officially become a corporate member of the Business Environment Council. As a leading professional advisory firm dedicated to advancing sustainability, we are firmly committed to empowering our clients to unlock growth opportunities through our Sustainability and Climate Solutions.

On June 16, 2023, the deputy secretary of the Party Committee of the China Appraisal Society (“CAS”) Mr. Yang Songtang and his delegation visited AVISTA Asset Appraisal (Beijing) Co., Ltd. (“AVISTA Appraisal”) to conduct in-depth research on how Hong Kong surveyors can better carry out appraisal work in mainland China. AVISTA Appraisal’s Founder and Managing